Academic literature on the topic 'Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia"
1
Ham, Ok Kyung, Bo Gyeong Lee, Eunju Choi, and Su Jung Choi. "Efficacy of Cognitive Behavioral Treatment for Insomnia: A Randomized Controlled Trial." Western Journal of Nursing Research 42, no. 12 (April 22, 2020): 1104–12. http://dx.doi.org/10.1177/0193945920914081.
Full textAbstract:
This study examined the effects of cognitive behavioral treatment for insomnia. A randomized controlled trial was performed on 44 women. The intervention included one group session of sleep hygiene education and four individual sessions of counseling. The instruments included the Insomnia Severity Index, Pittsburgh Sleep Quality Index, the Center for Epidemiological Studies Depression Scale, and Menopausal quality of life. The data were analyzed using repeated measure MANOVA, followed by repeated measure ANOVA. Repeated measure MANOVA showed that time had a significant main effect on the anthropometric variables (body mass index, waist circumference, and blood pressures) and revealed significant main effects of the group and time on the psychosocial variables (sleep quality, insomnia, depressive symptoms, and quality of life) ( p < .05). Repeated measure ANOVA results indicated a significant effect of the group on insomnia and sleep quality ( p < .05). Overall, the intervention was effective in improving insomnia and poor sleep quality.
2
Ionescu, Claudiu Gabriel, Ovidiu Popa-Velea, Alexandra Ioana Mihăilescu, Ana Anca Talaşman, and Ioana Anca Bădărău. "Somatic Symptoms and Sleep Disorders: A Literature Review of Their Relationship, Comorbidities and Treatment." Healthcare 9, no. 9 (August 30, 2021): 1128. http://dx.doi.org/10.3390/healthcare9091128.
Full textAbstract:
This study aimed to investigate the relationship between somatic symptom disorder (SSD) and sleep disorders, following three research questions: (1) How are these disorders correlated? (2) What are the comorbidities reported in these patients? and (3) What are the most effective pharmacological and non-pharmacological treatments for both conditions? PubMed, Scopus, OVID, Medline, and ProQuest databases were searched for relevant articles published between 1957–2020. Search terms included “somatic symptoms disorder”, “sleep disorders”, “insomnia”, “somatoform”, “somatization”, “therapeutic”, “psychotherapy”, and alternative, formerly used terms for SSD. Forty papers were finally included in the study. Prevalence of insomnia in SSD patients ranged between 20.4–48%, with this being strongly correlated to somatic symptoms and psychosocial disability. The most relevant comorbidities were generalized anxiety disorder, depression, fatigue, negative mood, substance use, orthorexia, alexithymia, anorexia, weight loss, poor eating habits, and acute stress disorder. Patients receiving antidepressant therapy reported significant improvements in insomnia and somatic symptoms. In terms of non-pharmacological interventions, cognitive-behavioral therapy (CBT) showed improvements in sleep outcomes, while the Specialized Treatment for Severe Bodily Distress Syndromes (STreSS) may represent an additional promising option. Future research could include other medical and psychosocial variables to complete the picture of the relationship between sleep disorders and somatic symptoms.
3
Jansson-Fröjmark, Markus, and Kalle Jacobson. "Cognitive behavioural therapy for insomnia for patients with co-morbid generalized anxiety disorder: an open trial on clinical outcomes and putative mechanisms." Behavioural and Cognitive Psychotherapy 49, no. 5 (January 28, 2021): 540–55. http://dx.doi.org/10.1017/s1352465821000023.
Full textAbstract:
AbstractBackground:Very little is known concerning the efficacy of psychosocial treatments for patients with insomnia disorder co-morbid with generalized anxiety disorder (GAD).Aim:The aim was to examine the efficacy of cognitive behavioral therapy for insomnia (CBT-I) for patients with insomnia disorder co-morbid with GAD.Method:Given the limited, previous research on therapies for patients with insomnia disorder co-morbid with GAD, an open trial design was used. Twenty-four patients with insomnia disorder and GAD were administered CBT-I across 10 weeks. Across the study period to 6 months follow-up, the participants completed measures indexing insomnia, anxiety, worry, depression, functional impairment, quality of life, treatment perception (credibility, expectancy and satisfaction), adverse events and putative mechanisms.Results:Moderate to large effect sizes for CBT-I were observed for insomnia symptoms. In terms of insomnia severity, approximately 61% of the patients responded to CBT-I and 26–48% remitted. Moderate to large effect sizes were also demonstrated for GAD symptoms, depression, functional impairment and quality of life. Roughly one-third of the participants reported an adverse event during CBT-I. Five of the seven putative mechanisms were significantly reversed in the expected direction, i.e. all four cognitive process measures and time in bed.Conclusions:This open trial indicates that CBT-I is an efficacious intervention for patients with insomnia disorder co-morbid with GAD. The results highlight the need for further research using a randomized controlled trial design with analyses of mechanisms of change.
4
Barnes, E. A., and E. Bruera. "Fatigue in patients with advanced cancer: A review." International Journal of Gynecologic Cancer 12, no. 5 (2002): 424–28. http://dx.doi.org/10.1136/ijgc-00009577-200209000-00002.
Full textAbstract:
Fatigue is the most common symptom in patients with advanced cancer. It is a subjective sensation with physical, cognitive, and affective modes of expression. The etiology is often unclear, and multiple potential etiologic factors for fatigue may coexist. Assessing fatigue involves characterizing its severity, temporal features, exacerbating and relieving factors, associated distress, and impact on daily life. Potential factors contributing to fatigue are the cancer itself, cancer treatment, cancer or treatment complications, medications, and other physical and psychosocial conditions. Many fatigue assessment tools exist. Fatigue management involves specific (targeting potentially reversible causes of fatigue) and symptomatic (targeting symptoms because no obvious etiology or reversible cause for fatigue can be identified) intervention and treatment measures. Specific interventions include treating anemia or metabolic and endocrine abnormalities, as well as managing pain, insomnia, depression, and anxiety. Symptomatic treatment involves education, counseling, and pharmacologic, and nonpharmacologic measures. Pharmacologic agents that have been investigated for use in treating fatigue include corticosteroids, progestational agents, and psychostimulants. Agents that modulate cytokine activity are future treatment possibilities.
5
Lowery-Allison, Amy E., Steven D. Passik, Matthew R. Cribbet, Ruth A. Reinsel, Barbara O'Sullivan, Larry Norton, Kenneth L. Kirsh, and Neil B. Kavey. "Sleep problems in breast cancer survivors 1–10 years posttreatment." Palliative and Supportive Care 16, no. 3 (May 16, 2017): 325–34. http://dx.doi.org/10.1017/s1478951517000311.
Full textAbstract:
ABSTRACTObjective:Sleep can affect quality of life (QoL) during cancer survivorship, and symptoms related to poor sleep can be exacerbated. We examined the prevalence, severity, and nature of subjective sleep complaints in women surviving stage I–III breast cancer who were 1–10 years posttreatment. We also examined the demographic, medical, physical, and psychosocial correlates of poor sleep in these women in order to identify the subgroups that may be most in need of intervention.Method:A total of 200 patients at a comprehensive cancer center who were 1–10 years posttreatment for primary stage I–III breast cancer with no evidence of disease at the time of enrollment completed a battery of questionnaires on demographics, sleep, physical symptoms, mood, cancer-specific fears, and QoL.Results:The women had a mean age of 57 years (SD = 10.0), with a mean of 63.3 months (SD = 28.8) of post-cancer treatment. Some 38% of these patients were identified as having poor-quality sleep. Women with poor sleep took longer to fall asleep, had more awakenings, and acquired 2 hours less sleep per night than those with good sleep. They also had a lower QoL, greater severity of pain, more concerns about health and recurrence, and increased vasomotor symptoms (p < 0.05). Daytime sleepiness and depression were found to be not significantly correlated with sleep quality.Significance of results:Many breast cancer survivors had severe subjective insomnia, and several breast cancer survivor subgroups were identified as having members who might be most in need of sleep-improvement interventions. Addressing physical symptoms (e.g., vasomotor symptoms and pain) and providing education about the behavioral, social, environmental, and medical factors that affect sleep could result in substantial improvement in the life course of breast cancer survivors.
6
Pinto Jr, Luciano Ribeiro, Rosana Cardoso Alves, Eliazor Caixeta, John Araujo Fontenelle, Andrea Bacellar, Dalva Poyares, Flavio Aloe, et al. "New guidelines for diagnosis and treatment of insomnia." Arquivos de Neuro-Psiquiatria 68, no. 4 (August 2010): 666–75. http://dx.doi.org/10.1590/s0004-282x2010000400038.
Full textAbstract:
The Brazilian Sleep Association brought together specialists in sleep medicine, in order to develop new guidelines on the diagnosis and treatment of insomnias. The following subjects were discussed: concepts, clinical and psychosocial evaluations, recommendations for polysomnography, pharmacological treatment, behavioral and cognitive therapy, comorbidities and insomnia in children. Four levels of evidence were envisaged: standard, recommended, optional and not recommended. For diagnosing of insomnia, psychosocial and polysomnographic investigation were recommended. For non-pharmacological treatment, cognitive behavioral treatment was considered to be standard, while for pharmacological treatment, zolpidem was indicated as the standard drug because of its hypnotic profile, while zopiclone, trazodone and doxepin were recommended.
7
Kozasa, Elisa Harumi, Helena Hachul, Carlos Monson, Luciano Pinto Jr., Marcelo Csermak Garcia, Luiz Eugênio de Araújo Moraes Mello, and Sérgio Tufik. "Mind-body interventions for the treatment of insomnia: a review." Revista Brasileira de Psiquiatria 32, no. 4 (December 2010): 437–43. http://dx.doi.org/10.1590/s1516-44462010000400018.
Full textAbstract:
OBJECTIVE: As insomnia is highly prevalent, and side effects of medication are well-known, mind-body interventions are increasingly being sought. The objective of this study is to present a narrative review regarding the effects of mind-body interventions for the treatment of insomnia. METHOD: A PubMed search was conducted including only randomized, controlled trials in which the main objective was to treat insomnia. DISCUSSION: Twelve studies were selected. In three of the studies, objective parameters (polysomnography) were analyzed. Mind-body interventions were able to improve sleep efficiency and total sleep time. Most can ameliorate sleep quality; some can reduce the use of hypnotic drugs in those who are dependent on these drugs. CONCLUSION: According to the studies we selected, self-reported sleep was improved by all mind-body treatments, among them yoga, relaxation, Tai Chi Chih and music. Cognitive behavioral therapy seems to be the most effective mind-body intervention. Cognitive behavioral therapy was the only intervention that showed better results than medication. However, considering that only five of the twelve studies chosen reached a score of 3 in the Jadad scale, new studies with a higher methodological quality have to be conducted especially in mind-body interventions that belong to the complementary or alternative medicine field.
8
Toner, Brenda B. "Cognitive-Behavioral Treatment of Irritable Bowel Syndrome." CNS Spectrums 10, no. 11 (November 2005): 883–90. http://dx.doi.org/10.1017/s1092852900019854.
Full textAbstract:
ABSTRACTThere is increasing evidence that supports the view that irritable bowel disorder (IBS) is a disorder of brain-gut function. Cognitive-behavioral therapy (CBT) has received increased attention in light of this recent shift in the conceptualization of IBS. This review has two main aims. The first is to provide a critical review of controlled trials on CBT for IBS. The second is to discuss ways of further developing CBT interventions that are more clinically relevant and meaningful to health care providers and individuals with a diagnosis of IBS. A theme from a CBT intervention will be presented to illustrate how CBT interventions can be incorporated within a larger social context. A review of CBT for IBS lends some limited support for improvement in some IBS symptoms and associated psychosocial distress. This conclusion needs to be expressed with some caution, however, in light of many methodological shortcomings including small sample sizes, inadequate control conditions and failure to identify primary versus secondary outcome measures. In addition, future studies will need to further develop more relevant CBT protocols that more fully integrate the patient's perspective and challenge social cognitions about this stigmatized disorder.
9
Bradshaw, William. "Cognitive-Behavioral Treatment of Schizophrenia: A Case Study." Journal of Cognitive Psychotherapy 12, no. 1 (January 1998): 13–25. http://dx.doi.org/10.1891/0889-8391.12.1.13.
Full textAbstract:
Cognitive-behavioral treatment (CBT) has rarely been applied as the primary treatment for the multiple, severe and persistent problems that characterize schizophrenia. This case study describes the process of CBT in the long-term outpatient care of a young woman with schizophrenia. The study highlights the adaptation of cognitive-behavioral strategies to the unique needs of schizophrenia and presents data regarding clinical outcomes in this case. Measures of psychosocial functioning, severity of symptoms, attainment of treatment goals and hospitalization data were used to assess change over the 3- year treatment period and at 1-year follow-up. Results indicate considerable improvement in all outcome variables and maintenance of treatment gains. These findings suggest the potential usefulness of cognitive-behavioral interventions in the treatment of schizophrenia.
10
Klomek, Anat Brunstein, and Barbara Stanley. "Psychosocial Treatment of Depression and Suicidality in Adolescents." CNS Spectrums 12, no. 2 (February 2007): 135–44. http://dx.doi.org/10.1017/s1092852900020654.
Full textAbstract:
ABSTRACTDepression is a common disorder among adolescents and is associated with a high risk of suicide. Suicide is the third leading cause of death among adolescents in the United States. Currently, there are only two evidence-based psychotherapies for adolescence depression: cognitive-behavioral therapy and interpersonal psychotherapy. Furthermore, psychosocial interventions that specifically target suicidal behavior in adolescents are even fewer in number than treatments for depression. This article will review the psychosocial interventions for depression and suicidality in adolescents and will describe a recently developed treatment that is under study for depressed suicidal adolescents.
Dissertations / Theses on the topic "Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia"
1
Vargas, Sara. "Does Sleep Mediate Improvements in Functional Adaptation After a Stress Management Intervention For Women With Breast Cancer?" Scholarly Repository, 2010. http://scholarlyrepository.miami.edu/oa_theses/288.
Full textAbstract:
The time of cancer diagnosis and treatment may be marked by an increase in stressors, which may be associated with poorer psychosocial and physical adaptation and increased sleep difficulty. Prior work has shown that psychosocial interventions that teach stress management skills can improve indicators of psychosocial and physical adaptation in women with breast cancer, mostly in cancer survivors who have completed treatment. The extant literature does not examine the effects of stress management on sleep, or the role that sleep plays in mediating psychosocial and physical adaptation outcomes, among women in the midst of treatment for non-metastatic breast cancer (BCa). Two hundred forty (240) women, recruited post-surgery from oncology practices, were randomly assigned to a 10-week group-based cognitive behavioral stress management intervention (CBSM; n = 120) or 1-day psychoeducation (PE) control (n = 120). The intervention consisted of didactics, CBSM techniques, and relaxation exercises, but did not specifically target sleep or sleep quality (SQ). Women assigned to the PE condition attended a one-day group seminar where they learned some of the material covered in the CBSM intervention, without the therapeutic group environment, role play techniques, and home practice. Participants completed self-report questionnaires at baseline, and at 6- and 12-month follow-ups. After controlling for days since surgery, participants in the CBSM group reported improved SQ, as well as increased positive states of mind, decreased disruption in social recreational functioning, and reduced fatigue-related daytime dysfunction for up to 8 - 12 months after baseline. There were marginally significant improvements in functional well-being and social functioning. CBSM was not associated with improvements in fatigue intensity. Improvements in SQ mediated CBSM-associated improvements in positive states of mind, social disruption, and fatigue-related daytime dysfunction. Thus, the CBSM intervention had beneficial effects on several indicators of functional adaptation that were in part explained by improvements in the quality of sleep. Future work should test the combined effects of stress management and sleep management interventions for women initiating treatment for BCa.
Books on the topic "Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia"
1
Kropf, Nancy, and Sherry Cummings. Evidence-Based Treatment and Practice with Older Adults. Oxford University Press, 2017. http://dx.doi.org/10.1093/acprof:oso/9780190214623.001.0001.
Full textAbstract:
Evidence Based Treatment with Older Adults: Theory, Practice, and Research provides a detailed examination of five research-supported psychosocial interventions for use with older adults: cognitive behavioral therapy, problem-solving therapy, motivational interviewing, psychoeducational and social support approaches, and life review/reminiscence. Taken together, these interventions address the diversity of mental health conditions and late-life challenges that older adults’ experience. Complementary chapters provide comprehensive treatment and research information for each intervention. In the first chapter for each treatment, theoretical concepts undergirding the intervention are explained and the specific skills and techniques employed are clearly described. Adaptations for use of each intervention with older adults are highlighted. Vignettes demonstrate the application of particular intervention strategies with older clients, while case studies provide a comprehensive presentation of the intervention. In a second chapter on the intervention, the research base supporting the use of the specific approach with older adults is reviewed and analyzed. In addition, the distinct issues, such as depression, anxiety, substance abuse/misuse, behavioral health challenges, and insomnia, for which evidence exists are highlighted. Research support for application of the interventions in community-based, acute care, and long-term care settings and in individual and group formats is discussed. Implementation issues encountered in therapeutic work with older adults are described, as are accommodations to enhance treatment efficacy. Finally, a chapter on future directions in geriatric interventions provides an overview of emerging therapies that hold promise for the treatment of older adult mental health. In sum, this book provides a comprehensive overview of research-supported psychosocial interventions for older adults and their care providers.
2
Beckman, Nancy J., and Marie B. Tobin. Psychiatric Comorbidities in Chronic Pain Syndromes. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190271787.003.0033.
Full textAbstract:
Psychiatric comorbidities are common in patients with chronic pain syndromes. Depression, anxiety, insomnia, somatic symptom disorder, substance use disorders, personality disorders, and problematic coping strategies present unique treatment challenges to pain medicine specialists. Patients with these comorbidities tend to have poorer response to treatment, higher rates of complications, and greater pain-related suffering. To reduce stigma, providers are encouraged to define pain as both a sensory and emotional experience. This intimate connection implies that optimal pain treatment requires concurrent attention to psychosocial well-being. Overlapping biological and psychologic mechanisms in the development of chronic pain and psychiatric disorders may contribute to the high rates of comorbidity. Methods for quickly identifying psychiatric disorders within busy clinic settings and brief interventions that pain specialists can deliver are described. Finally, indications for referral to specialty mental health and the benefits of multidisciplinary treatment, which can include psychiatric medications and evidence-based psychologic treatments, such as cognitive-behavioral therapy, are discussed.
3
Roth, Andrew, and Chris Nelson. Psychopharmacology in Cancer Care. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780197517413.001.0001.
Full textAbstract:
Clinicians who care for adult cancer patients have many tools to manage symptoms of depression, anxiety, cognitive changes, insomnia, and fatigue. Non-prescribing clinicians, such as psychologists, nurses, social workers, and occupational and physical therapists, provide frontline psychosocial interventions and physical support for cancer patients. Psychotropic treatments are sometimes required to resolve complex syndromes that mingle both medical and psychiatric features. Psychiatric medications are most frequently prescribed to cancer patients by oncologists, general medical practitioners, general psychiatrists, and psychiatric advanced practice providers such as nurse practitioners and physician assistants, as few oncology practices have dedicated psycho-oncologists. Non-prescribing practitioners who care for people with cancer are often the first to identify a psychiatric syndrome that requires a referral for psychopharmacologic intervention. They can also play an important role in educating patients about how psychopharmacologic agents can augment their cancer care. After psychotropic medications are started, non-prescribers can observe for improvement and detect problematic side effects if they arise, thus improving adherence with medication regimens. Practitioners who read this book will benefit from the highlighted clinical pearls to follow, and the potholes to avoid, regarding the tricky diagnostics and pharmacologic treatment of psychiatric syndromes. All clinicians will learn communication strategies that bridge distances of professional specialty and geography so that treatment by multiple providers may be more seamless, which it is hoped will enrich outcomes, both medical and emotional.
4
Gannon, Jessica M., and Shaun M. Eack. Psychosocial Treatment for Psychotic Disorders: Systems of Care and Empirically Supported Psychosocial Interventions. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199331505.003.0007.
Full textAbstract:
In this chapter, we discuss psychosocial interventions, including psychotherapies and other services useful for helping individuals with psychotic disorders. We explain the basics components of the systems of care through which these services are frequently offered, focusing on outpatient treatments. Psychosocial rehabilitation is highlighted, as it helps patients move towards recovery, which is an important model for psychosocial care. A number of evidence-based psychotherapies are explored, notably cognitive-behavioral therapy (CBT), family therapy, and cognitive remediation. Many of these treatments can be given individually or in groups, and although underutilized, can improve outcome when combined with somatic therapies. Other services have been shown to be useful in recovery, such as case management, assertive community treatment, and housing, and these are explored in this chapter as well. Finally, we review the role of hospitalization and involuntary treatment in the care of patients with psychotic disorders.
5
Rose, Raquel, and Nicolette Molina. Interventions. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190260859.003.0010.
Full textAbstract:
Despite the fact that suicide is one of the leading causes of death in the United States, there are currently no US Food and Drug Administration-approved treatments for suicidal behavior. However, interventions that provide potentially effective treatment are available. This chapter explores medications and biological interventions as well as psychosocial, alternative, and app/Internet-based interventions. The section on medications and biological interventions covers clozapine, lithium, and ketamine. The psychosocial intervention section covers dialectical behavior therapy, cognitive–behavioral therapy for suicidal patients (CBT-SP), Collaborative Assessment and Management of Suicidality (CAMS), attachment-based family therapy, and safety planning. The section on alternative and Internet-based interventions covers mindfulness meditation as well as online applications that can act as supplements to traditional treatments. The chapter concludes with a reminder of the importance of suicide risk assessment and clinician self-care in suicide prevention.
6
Soffer, Jocelyn, César A. Alfonso, John Grimaldi, and Jack M. Gorman. Psychotherapeutic Interventions. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0037.
Full textAbstract:
Psychotherapeutic care for persons with HIV is an important component of overall treatment, helping people to cope and decreasing the psychological suffering that may be attendant when navigating the complex array of biopsychosocial stresses and challenges of living with HIV. A combination of psychotherapeutic and psychosocial interventions can effectively address psychological aspects of functioning and reduce psychiatric symptoms, as well as improve adherence to risk reduction and medical care. This chapter reviews several psychotherapeutic interventions, including supportive, psychodynamic, and interpersonal psychotherapy, cognitive-behavioral therapy, and motivational interviewing. Both individual and group settings are discussed, as well as the particular settings of spiritual care, family therapy, and couples therapy.
7
Blonigen, Daniel M., John W. Finney, Paula L. Wilbourne, and Rudolf H. Moos. Psychosocial Treatments for Substance Use Disorders. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199342211.003.0023.
Full textAbstract:
The most effective psychosocial modalities for treating substance use disorders are cognitive-behavioral interventions, motivational interviewing and motivational enhancement, contingency management, community reinforcement, behavioral couples and family therapies, and 12-step facilitation approaches. The foci of these interventions include substance use behavior, patients’ life contexts, and their social and personal resources. Limited evidence is available for these interventions’ differential effectiveness. Brief interventions are highly effective in the treatment of alcohol use disorders. However, as stand-alone treatments, they are best suited for individuals with mild to moderate alcohol use problems. Therapists who are interpersonally skilled, empathic, and nonconfrontational, and who develop a strong therapeutic alliance, are more effective at helping patients achieve better outcomes.
8
Franklin, Martin E., Diana Antinoro, Emily J. Ricketts, and Douglas W. Woods. Treatment of Tic Disorders and Trichotillomania. Edited by Gail Steketee. Oxford University Press, 2012. http://dx.doi.org/10.1093/oxfordhb/9780195376210.013.0095.
Full textAbstract:
This chapter briefly describes tic disorders and trichotillomania (TTM) and reviews the pharmacotherapy and psychosocial treatment outcome literature for each of these conditions. In contrast to anxiety or depression, distorted or maladaptive cognitions do not appear to play a central role in the etiology or maintenance of tic disorders and TTM, and therefore cognitive therapy is not emphasized in the psychosocial treatments studied to date. Treatment protocols are best characterized as “behavioral,” although some include ancillary cognitive interventions. Behavioral treatments that include habit reversal training (HRT) appear to hold the greatest promise for each of these conditions, and these are described in some detail. Future directions in treatment research are suggested.
9
Steinberg, Martin. Treatment of Depression. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199959549.003.0006.
Full textAbstract:
Most depression in the elderly can be effectively treated in the primary care setting. Psychiatric referral should be considered in the setting of severe depression, suicidal ideation, prior suicide attempts, multiple risk factors, psychotic symptoms, bipolar disorder, poor response to prior treatment, or high medical comorbidity. Combining pharmacological and psychosocial interventions is most likely to be effective. Available antidepressants include serotonin-specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, novel mechanism agents, tricyclic antidepressants, and monoamine oxidase inhibitors. Antidepressant selection should take into account adverse effects, medical comorbidities, potential medication interactions, and patient preferences. Additional strategies (e.g. augmentation) are available for treatment resistant depression. Available psychotherapies include supportive, cognitive-behavioral, interpersonal, and problem solving. Lifestyle interventions (e.g. exercise) may be helpful adjuncts. Given limited evidence for antidepressant treatment in cognitive impairment, for those with mild to moderate depression severity, non-pharmacological interventions should be attempted first.
10
Muralidharan, Anjana, David J. Miklowitz, and W. Edward Craighead. Psychosocial Treatments for Bipolar Disorder. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780199342211.003.0010.
Full textAbstract:
Pharmacological interventions remain the primary treatment for bipolar disorder. However, adjunctive psychosocial interventions have the potential to increase adherence to medication regimens, decrease hospitalizations and relapses, decrease severity of symptoms, improve quality of life, and enhance mechanisms for coping with stress. Group psychoeducation, designed to provide information to bipolar patients about the disorder and its treatment, leads to lower rates of recurrence and greater adherence to medication among remitted bipolar patients at both short- and long-term follow-up. Cognitive-behavioral therapy as an ancillary treatment has found mixed results but generally supportive evidence indicating that it is useful in preventing relapse to depression in remitted patients. Family-based intervention, such as Family-Focused Therapy (FFT), may be combined with pharmacotherapy to reduce recurrences and hospitalization rates in adult patients.
Book chapters on the topic "Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia"
1
Andersen, Barbara L., Nicole A. Arrato, and Caroline S. Dorfman. "Cognitive and Behavioral Interventions." In Psycho-Oncology, edited by William S. Breitbart, Phyllis N. Butow, Paul B. Jacobsen, Wendy W. T. Lam, Mark Lazenby, and Matthew J. Loscalzo, 416–23. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190097653.003.0053.
Full textAbstract:
Cognitive and behavioral interventions are effective in treating mood and anxiety disorders in patients with cancer. Screening for disorders is more common, but referral (and uptake) of psychosocial services remains low relative to patient need. Efficacious, cognitive behavioral treatments (CBTs) are first-line treatments for adults with major depressive disorder (MDD) and generalized anxiety disorder (GAD), and there is accumulating evidence for CBT effectiveness for individuals with cancer. For those not yet diagnosed but with elevated symptoms, CBT has reduced symptoms and shown physical symptom and health-related quality-of-life improvements. Fewer studies have accrued patients diagnosed with MDD or GAD, but those studies also show CBT to be similarly effective. Thus far, CBT trials with MDD/GAD comorbidity, a common occurrence and negative prognostic factor, have not been conducted. CBT replication and extension trials are needed to confirm CBT as the treatment of choice for patients with psychiatric disorders.
2
"Cognitive-Behavioral Therapy and Other Psychosocial Interventions for Substance Use Disorders." In Substance and Nonsubstance Related Addiction Disorder: Diagnosis and Treatment, edited by Aly Hassan, Shashi K. Bhatia, and Subhash C. Bhatia, 227–42. BENTHAM SCIENCE PUBLISHERS, 2017. http://dx.doi.org/10.2174/9781681083438117010023.
Full text
3
Kazdin, Alan E. "Evidence-Based Psychosocial Interventions." In Innovations in Psychosocial Interventions and Their Delivery, edited by Alan E. Kazdin, 77–109. Oxford University Press, 2018. http://dx.doi.org/10.1093/med-psych/9780190463281.003.0004.
Full textAbstract:
This chapter discusses the development of psychosocial interventions with supportive evidence in their behalf. The goals of these evidence-based psychosocial interventions are to reduce psychological dysfunction related to affect, cognition, and behavior and psychiatric disorders that can impair everyday functioning. The range of treatments with an evidence base is vast and includes multiple cognitive and behavioral treatments, traditional therapies, and many “treatments as usual.” This chapter provides a description of the current status of treatment, as well as the challenges related to interpretation of findings and the generality of findings from research to practice.
4
Polak, Kathryn, Sydney Kelpin, Jarrod Reisweber, and Dace S. Svikis. "Evidence-Based Behavioral Therapies for Substance Use Disorders." In Substance Use Disorders, 267–82. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190920197.003.0015.
Full textAbstract:
A variety of pharmacological and psychosocial interventions have demonstrated efficacy in the treatment of substance use disorders (SUDs). This chapter focuses on evidence-based behavioral and psychosocial interventions for the treatment of alcohol use disorder and other SUDs. Among the interventions discussed are screening, brief intervention, and referral to treatment (SBIRT); motivational interviewing (MI); cognitive behavioral therapy (CBT); and contingency management (CM). Additionally, one promising intervention for SUD, Transcending Self Therapy (TST), is spotlighted. The importance of comprehensive care is noted by the authors, as is the importance of recognizing gender differences in the selection of therapies and the need to address barriers to care for specific populations.
5
Finney, John W., Paula L. Wilbourne, and Rudolf H. Moos. "Psychosocial Treatments for Substance Use Disorders." In A Guide to Treatments that Work, 179–202. Oxford University Press, 2007. http://dx.doi.org/10.1093/med:psych/9780195304145.003.0006.
Full textAbstract:
Our review of the literature indicates that among the most effective treatments for alcohol and illicit drug use disorders are cognitive-behavioral treatments, community reinforcement and contingency management approaches, 12-step facilitation and 12-step treatment, behavioral couples and family treatment, and motivational enhancement interventions. Most of these treatment modalities address not only drinking and/or drug use behavior but also patients’ life contexts, sense of self-efficacy, and coping skills; motivational interventions focus primarily on attempts to enhance individuals’ commitment to behavior change. Consistent with motivational interviewing principles, therapists who are interpersonally skilled, empathic, and less confrontational produce better patient outcomes, probably because they establish better therapeutic alliances with their patients. An effective strategy for many patients may be to provide lower intensity treatment for a longer duration—that is, treatment sessions spread at a lower rate over a longer period to match better the chronic, relapsing nature of many individuals’ substance use disorders. At this point, it seems wise to restrict brief interventions as a stand-alone treatment to patients with mild to moderate disorders. Longer term interventions and treatment in inpatient or residential settings should be reserved for patients with more severe, treatment-resistant substance use disorders, fewer social resources, more concomitant medical/psychiatric disorders, and a desire for longer term and/or residential treatment.
6
Soffer, Jocelyn, and Mary Ann Cohen. "Psychotherapeutic Treatment of Psychiatric Disorders." In Handbook of AIDS Psychiatry. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372571.003.0012.
Full textAbstract:
Persons living with HIV and AIDS face a complex array of stresses and challenges, as discussed throughout this book, which may overwhelm psychological functioning. This leads to considerable distress and suffering (Cohen et al., 2002), manifests in a multitude of psychiatric symptoms, and increases nonadherence to risk reduction and medical care. The aim of psychotherapeutic care for persons with HIV is to mitigate such distress through a combination of psychosocial interventions. Goals of such therapies may include enhancing adaptive coping strategies, facilitating adjustment to living with HIV, increasing social supports, and improving a patient’s sense of purpose, self-esteem, and overall well-being. Goals may also include improving adherence to risk reduction and medical care, as well as preventing HIV transmission. Psychological distress in persons with HIV infection is associated with decreased quality of life, disease progression, and mortality (Leserman, 2008). Considering the biopsychosocial model, emotional distress in HIV can be viewed as resulting from a combination of medical, psychological, and social factors related to the illness (see Table 8.1). In some studies, improved social support and active coping styles in response to illness and stress have correlated with improved immunological parameters. Studies have also linked depressed mood and stressful life events to worsened immunological status, including decreased CD4 cell counts. Nonetheless, randomized controlled data demonstrating the ability of behavioral and social interventions to improve immune status remain conflicted; further evidence-based research is needed. While improving immunological status is a potential benefit of psychosocial treatment for people with HIV infection, it is relieving the suffering inherent to psychiatric illness and improving patients’ quality of life that remain the primary goals. A variety of psychosocial interventions are available to persons with HIV, from individual to group-based formats. Such treatments span a spectrum of psychotherapeutic approaches, including supportive, psychodynamic, interpersonal, and cognitive-behavioral. This chapter will consider the benefits of such psychosocial interventions by summarizing the current state of research and findings for each of these treatment approaches, addressing both individual and group settings.
7
Miklowitz, David J., and W. Edward Craighead. "Psychosocial Treatments for Bipolar Disorder." In A Guide to Treatments that Work, 309–22. Oxford University Press, 2007. http://dx.doi.org/10.1093/med:psych/9780195304145.003.0011.
Full textAbstract:
Whereas pharmacological interventions remain the primary treatment for bipolar disorder, adjunctive psychosocial interventions have the potential to increase adherence to medication regimens, decrease hospitalizations and relapses, improve quality of life, and enhance mechanisms for coping with stress. Controlled studies have established that individual, family, and group psychoeducation, designed to provide information to bipolar patients and their families about the disorder, its pharmacological treatment, and the treatments’ side effects, leads to lower rates of recurrence and greater adherence to pharmacological treatment among bipolar patients. Type 1 and 2 studies have evaluated cognitive behavioral therapy (CBT) as an ancillary treatment. These studies indicate that CBT is associated with better medication adherence and significantly fewer recurrences and/or rehospitalizations. One Type 1 study has evaluated the effectiveness of IPSRT (interpersonal and social rhythm therapy) for bipolar disorder. IPSRT demonstrated its greatest symptomatic effects during a maintenance treatment period, especially if bipolar patients had been successful in stabilizing their daily and nightly routines during an acute treatment period. Finally, four Type 1 studies in adult and pediatric patients have shown that marital/ family therapy may be effectively combined with pharmacotherapy to reduce recurrences and improve medication adherence and family functioning.
8
Wiener, Lori, Marie Barnett, Stacy Flowers, Cynthia Fair, and Amanda L. Thompson. "Evidence-Based Psychosocial Interventions in Pediatric Psycho-Oncology." In Psycho-Oncology, edited by William S. Breitbart, 703–14. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780190097653.003.0088.
Full textAbstract:
Children with cancer and their families experience significant emotional distress throughout the cancer trajectory. Evidence-based psychosocial interventions can alleviate suffering and promote adaptation and positive coping strategies. This chapter reviews interventions frequently used within pediatric oncology settings, including evidence-based approaches and those with limited empirical data to date. Interventions utilized at initial diagnosis, during active treatment, throughout survivorship, and at end of life and bereavement are presented. Strategies such as psychoeducation, procedural support for children, mind-body interventions, play and expressive techniques, cognitive-behavioral therapy, acceptance and commitment therapy, adherence interventions, support groups, communication, and advanced care planning tools are described along with available efficacy information. Data is also presented to describe the interventions most commonly used by pediatric psychosocial providers when caring for children with cancer and their families. The development of evidence-based standards of psychosocial care highlight the significant progress made toward supporting children with cancer and their families. Gaps in interventions are addressed, particularly on developmental and culturally sensitive approaches, school re-entry support, pediatric to adult care transitions, individual bereavement interventions, and intervention format/delivery. The field of pediatric psycho-oncology would benefit from ongoing translation of science into practice and increased access to evidence-based interventions.
9
Gupta, Tanu, and Kartik Singhai. "Mindfulness-Based Interventions in Attention Deficit Hyperactivity Disorder." In Handbook of Research on Clinical Applications of Meditation and Mindfulness-Based Interventions in Mental Health, 144–52. IGI Global, 2022. http://dx.doi.org/10.4018/978-1-7998-8682-2.ch009.
Full textAbstract:
Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent neurodevelopmental disorder in children and adolescents. It is marked with deficits in behavioral symptoms of hyperactivity/impulsivity along with cognitive deficits in the domain of attention, self-regulation, and executive function. Mindfulness-Based Interventions (MBI) have come up as an intervention of choice for various psychological disorders such as anxiety disorder, depression, substance abuse, and eating disorder. Mindfulness at its core is paying non-judgmental attention to the present moment. Despite the robust evidence for both of the treatment modalities available, the cognitive symptoms of ADHD still progress towards adulthood affect the individual's achievement and overall psychosocial adjustment. A number of recent studies have found preliminary evidence about the effectiveness of MBI as an adjunct treatment in ADHD. The chapter will discuss the evidence-based interventions that incorporate mindfulness.
10
Rastegar, Darius A. "Overview of Substance Use Disorder Treatment." In ASAM Handbook of Addiction Medicine, 29–42. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780197506172.003.0003.
Full textAbstract:
Treatment of substance use disorders (SUD) has traditionally been program-centered, but patient-centered models hold the promise of care that is more ethical and effective. Most SUD treatments can be roughly divided into two types of modalities: psychosocial treatment, which includes brief interventions, self-help groups, counseling, cognitive–behavioral therapy, and analytic psychotherapy; and pharmacotherapy, which includes drug antagonists or agonists and other agents. These treatments are not mutually exclusive, and the best approach in many cases is a combination of therapeutic modalities. The American Society of Addiction Medicine has developed placement criteria to help determine the optimal treatment setting. Harm reduction is an approach that focuses on reducing the harms of drug use without necessarily targeting drug use itself.
Conference papers on the topic "Psychosocial Interventions; Cognitive-behavioral Treatment For Insomnia"
1
Zavrel, Erik A., and Matthew R. Ebben. "An Active Distal Limb Warming Device for Insomnia Treatment." In 2017 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/dmd2017-3469.
Full textAbstract:
The defining characteristics of insomnia are widely recognized as difficulty falling asleep, difficulty staying asleep, and sleep that is non-restorative [1]. Insomnia is among the most common health complaints: about 10% of the adult population complains of a chronic insomnia problem [2]. With aging, increasingly disturbed sleep and less satisfaction with sleep quality are reported [3]. This common problem has wide ranging physiological, cognitive, and behavioral consequences including higher healthcare utilization [4–6]. Current major treatment options for insomnia (hypnotic medications and non-pharmacological behavioral interventions) suffer side effects and shortcomings. Thermoregulation plays a key role in promoting and maintaining sleep. At night, core body temperature (CBT) drops while distal skin temperature (DST) increases. It was previously believed that the nighttime drop in CBT was the most important promoter of sleep. However, recent research has shown that it is in fact the increase in DST (with net body heat loss owing to the large distal skin surface area) which is associated with an increase in sleepiness, whereas a decrease in DST (with resulting net body heat retention) is associated with a decrease in sleepiness [7]. The amount of distal vasodilation, as measured by the distal-proximal skin temperature gradient (DPG), is more predictive of sleep onset than subjective sleepiness ratings, CBT, or dim light melatonin onset. In fact, “the degree of dilation of blood vessels in the skin of the hands and feet, which increases heat loss at these extremities, is the best physiological predictor for the rapid onset of sleep” [8]. The link between distal skin warming and sleep propensity is further strengthened by the fact that warm water immersion of hands and feet has been found to decrease sleep onset latency (SOL) and pre-sleep warm baths have long been prescribed as an insomnia treatment. In a recent study, we used a multiple sleep latency test (MSLT) to perform multiple nap trials throughout the day, with the participants’ hands and feet immersed in warm water prior to each nap. We found that both mild and moderate warming of the hands and feet prior to a nap significantly reduced SOL compared to a baseline MSLT without warming [9]. We also previously conducted a trial of temperature biofeedback for insomnia treatment in which we demonstrated SOL reduction using muscle relaxation techniques to induce distal vasodilation, increase blood flow to the extremities, and modulate temperature of hands and feet [10]. Additionally, it has been shown that regardless of circadian variation throughout the day, finger temperature shows a rapid increase immediately before sleep onset [11]. Lastly, people with primary vascular dysregulation (a condition caused by abnormal vasoconstriction that results in cold hands and feet) exhibit significantly increased SOL and greater difficulty falling asleep following nocturnal arousal [12]. Thus, some presentations of insomnia may be secondary to distal vasodilation failure. The motivation for an active distal limb warming device as a treatment for insomnia is based on the established functional link between distal vasodilation and sleep induction [13]. Somewhat counterintuitively then, heating of hands and feet can induce distal vasodilation, promote net body heat loss, and facilitate sleep onset [14, 15].